| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_962988563d1b74a93d729275231c4fa0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-541 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2016-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79c27686235ccd1b378dfd4a2548e6eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98a4e59ff353fd93d8b965e66c07b06f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_429e243cf87f5636e5e27db1d2efe768
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c2e237cc70fbd0eca9979e7d6588162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cb40d4edc7256bc6cc6ee6e52031833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fdf502a48bae834e998e04c5899ad75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e441842b225d0b49a38382d2b23a6230
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b95d391a757ce34b31df1a7bc71c8fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b981355e1a4210734df2bb84786a52d |
| publicationDate |
2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107164252-A |
| titleOfInvention |
A Subunit Vaccine of RHDV |
| abstract |
The present invention provides a RHDV subunit vaccine. Specifically, the inventor obtained a method for preparing rabbit hemorrhagic disease virus VLP particles through extensive and in-depth research. The invention provides a genetically engineered cell, the genetically engineered cell is a eukaryotic cell, and an expression cassette expressing the VP60 protein of rabbit hemorrhagic disease virus is integrated in the genome of the cell; or the cell contains an expression vector, the The expression vector contains an expression cassette expressing the VP60 protein of the rabbit hemorrhagic disease virus; and the genetically engineered cell expresses the VP60 protein in the cell, and the VP60 protein forms a virus-like particle (VLP) inside the genetically engineered cell ). The invention also provides virus-like particles (VLP) expressed by the genetically engineered cells. Experimental results show that the genetically engineered cells and method according to the present invention can efficiently prepare rabbit hemorrhagic disease virus VLP particles. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111575315-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110317794-A |
| priorityDate |
2016-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |